Ilson Delves Into the Development of Checkpoint Inhibition in Gastric/GEJ Cancers

Dr. Ilson discusses treatment sequencing for patients with gastric and gastroesophageal junction cancer, the integration of immunotherapy into the frontline setting, and key ongoing studies in the field.